Results 141 to 150 of about 4,076 (204)

Comparison of ABBV-552 Safety and Pharmacokinetics in Healthy Asian and Western Adults. [PDF]

Clin Pharmacol Drug Dev
Miles N, McNamee B, Zadikoff C, Boiser J, Shebley M, Boinpally R.   +5 more
europepmc   +1 more source

PET-based molecular imaging in neurodegeneration and dementia: current and emerging radiotracers. [PDF]

Radiol Adv
Gil N, Naik P, Koran ME, Silverman D, Kako B, Chen J.   +5 more
europepmc   +1 more source

SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. [PDF]

Proc Natl Acad Sci U S A
Chia PHJ, Toyonaga T, Tong J, Le H, Dias M, Boyle AJ, Raymond R, Longbrake EE, Huang Y, Carson RE, Airas L, Vasdev N, Chen MK, Zheng C.   +13 more
europepmc   +1 more source

Brivaracetam-associated manic episode in a patient with bipolar disorder: A case report. [PDF]

PCN Rep
Kawai M, Miyata J, Kanemoto K.
europepmc   +1 more source

Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization. [PDF]

Aging Cell
Wang X, Zhang Q, Zhang X, Liu J, Zhang J, Liu C, Cui Y, Song Q, Hou Y, Wang Y, Cao M, Wang P.   +11 more
europepmc   +1 more source

SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response. [PDF]

Epilepsia
Lang J, Linnerbauer M, Cuny J, Rothhammer V, Hamer H.   +4 more
europepmc   +1 more source

HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [¹¹C]-UCB-J PET imaging. [PDF]

NeuroImmune Pharm Ther
Yadav TC, Orsucci IC, Thompson SV, Wu Z, Li Z, Yuan H, Yadav-Samudrala BJ, Fitting S.   +7 more
europepmc   +1 more source

Imaging Synaptic Vesicle Protein SV2C with ¹⁸F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study. [PDF]

ACS Chem Neurosci
Nag S, Sousa VC, Zou R, Morén AF, Datta P, Khani Y, Valade A, Vermeiren C, Motte P, Mercier J, Ågren H, Halldin C, Varrone A.   +12 more
europepmc   +1 more source

Altered lipid peroxidation, perineuronal net and oligodendrocyte markers in the frontal cortex of a dual-hit neurodevelopmental model support its relevance to schizophrenia. [PDF]

Front Cell Neurosci
Esuaikoh V, Ibegbulam S, Cook A, McFarland B, Nunnington N, Perera A, Feng J, Cale JA, King MV.   +8 more
europepmc   +1 more source

Lower synaptic density in mood circuitry underlies depression in Parkinson's disease. [PDF]

Brain Commun
Cayir S, Naganawa M, Volpi T, Ebrahimian Sadabad F, Dias M, Yang Y, Elliott S, Ansari M, Elshahat A, Pittman B, Esterlis I, Nabulsi N, Huang Y, Sanacora G, Comley R, Finnema SJ, Carson RE, Tinaz S, Matuskey D, Holmes SE.   +19 more
europepmc   +1 more source